Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-16

Clinical Trial Update: Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update for intranasal ketamine as an adjunct to fentanyl for prehospital treatment of acute traumatic pain; trial status ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENTANYL (FENTANYL)
  • Intranasal ketamine (ketamine)

Snippet

Sponsor: Jason McMullan | Conditions: Acute Traumatic Pain | Phase 3 | Status: ACTIVE_NOT_RECRUITING